Skip to main content Skip to main navigation menu Skip to site footer
  • \
    Start Submission Become a Reviewer

    Advancements and application of sustainable nanotechnology-based biomedical products in cancer therapeutics

    • Vinita Sharma
    • Jurnal Reang
    • Vivek Yadav
    • Archana Sharma
    • Jaseela Majeed
    • Prabodh Chander Sharma


    Abstract

    Nanotechnology has gained widespread attention in various scientific fields due to the special properties of nanomaterials. Sustainable nanotechnology prioritizes minimizing the environmental impact of nanomaterials and manufacturing processes while ensuring biocompatibility and safety. By utilizing eco-friendly materials, renewable energy sources, and greener production techniques, sustainable nanotechnology addresses the pressing need for eco-conscious advancements in cancer treatment. The integration of sustainable nanotechnology with advanced imaging techniques enables precise tumor detection, characterization, and monitoring. To improve cancer treatment, sustainable nanotechnology-based novel carriers have attracted significant attention, which includes proteins, solid lipid nanoparticles, nanostructured lipid carriers, polymeric nanoparticles, micelles, dendrimers, and antibody-drug conjugates that are employed for the co-delivery of phytochemicals and anticancer agents at the targeted sites. Green synthesis approaches to nanomaterials have gained attention due to their sustainability and environmental friendliness. Nevertheless, there are issues with this synthesis process, like bulk manufacturing, cytotoxicity of nanomaterials, and safe solvent selection. Furthermore, several of the anticipated sustainable nanotechnologies, such as gene- and immunotherapy-based nanoformulations and therapeutics, have redefined existing nanotechnologies. This review aims to provide a comprehensive overview of eco-friendly and sustainable nanotechnology for cancer diagnostics and treatment, emphasizing the efficacy, safety, and environmental sustainability of current nanotechnology in cancer treatments.

    Keywords: Sustainable Nanotechnology Diagnostics Nano-formulations Cancer Theragnostic
    Section

    References

    1. Abbasi, E., Aval, S. F., Akbarzadeh, A., Milani, M., Nasrabadi, H. T., Joo, S. W., Hanifehpour, Y., Nejati-Koshki, K., & Pashaei-Asl, R. (2014). Dendrimers: synthesis, applications, and properties. Nanoscale Research Letters, 9(1), 247. https://doi.org/10.1186/1556-276X-9-247
    2. Adrita, S. H., Tasnim, K. N., Ryu, J. H., & Sharker, S. M. (2020). Nanotheranostic Carbon Dots as an Emerging Platform for Cancer Therapy. In Journal of Nanotheranostics (Vol. 1, Issue 1, pp. 58–77). https://doi.org/10.3390/jnt1010006
    3. Aggarwal, R. R., Feng, F. Y., & Small, E. J. (2017). Emerging Categories of Disease in Advanced Prostate Cancer and Their Therapeutic Implications. Oncology (Williston Park, N.Y.), 31(6), 467–474.
    4. Aghamiri, S., Mehrjardi, K. F., Shabani, S., Keshavarz-Fathi, M., Kargar, S., & Rezaei, N. (2019). Nanoparticle-siRNA: a potential strategy for ovarian cancer therapy? Nanomedicine, 14(15), 2083–2100. https://doi.org/10.2217/nnm-2018-0379
    5. Aikins, M. E., Xu, C., & Moon, J. J. (2020). Engineered Nanoparticles for Cancer Vaccination and Immunotherapy. Accounts of Chemical Research, 53(10), 2094–2105. https://doi.org/10.1021/acs.accounts.0c00456
    6. Alt, M., Stecca, C., Tobin, S., Jiang, D. M., & Sridhar, S. S. (2020). Enfortumab Vedotin in urothelial cancer. Therapeutic Advances in Urology, 12, 1756287220980192. https://doi.org/10.1177/1756287220980192
    7. Alven, S., & Aderibigbe, B. A. (2020). The Therapeutic Efficacy of Dendrimer and Micelle Formulations for Breast Cancer Treatment. In Pharmaceutics (Vol. 12, Issue 12). https://doi.org/10.3390/pharmaceutics12121212
    8. Anani, T., Rahmati, S., Sultana, N., & David, A. E. (2021). MRI-traceable theranostic nanoparticles for targeted cancer treatment. Theranostics, 11(2), 579–601. https://doi.org/10.7150/thno.48811
    9. Andriole, G., Crawford, E., Grubb, R., Buys, S., Chia, D., Church, T., Fouad, M., Isaacs, C., Kvale, P., Reding, D., Weissfeld, J., Yokochi, L., O’Brien, B., Ragard, L., Clapp, J., Rathmell, J., Riley, T., Hsing, A., Izmirlian, G., & Prorok, P. (2012). Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up. Journal of the National Cancer Institute, 104, 125–132. https://doi.org/10.1093/jnci/djr500
    10. Ashford, M. B., England, R. M., & Akhtar, N. (2021). Highway to Success—Developing Advanced Polymer Therapeutics. Advanced Therapeutics, 4(5), 2000285. https://doi.org/https://doi.org/10.1002/adtp.202000285
    11. Aslan, B., Ozpolat, B., Sood, A. K., & Lopez-Berestein, G. (2013). Nanotechnology in cancer therapy. Journal of Drug Targeting, 21(10), 904–913. https://doi.org/10.3109/1061186X.2013.837469
    12. Auffan, M., Rose, J., Bottero, J.-Y., Lowry, G. V, Jolivet, J.-P., & Wiesner, M. R. (2009). Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nature Nanotechnology, 4(10), 634–641. https://doi.org/10.1038/nnano.2009.242
    13. Babu, A., Muralidharan, R., Amreddy, N., Mehta, M., Munshi, A., & Ramesh, R. (2016). Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy. IEEE Transactions on Nanobioscience, 15(8), 849–863. https://doi.org/10.1109/TNB.2016.2621730
    14. Begines, B., Ortiz, T., Pérez-Aranda, M., Martínez, G., Merinero, M., Argüelles-Arias, F., & Alcudia, A. (2020). Polymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects. Nanomaterials (Basel, Switzerland), 10(7). https://doi.org/10.3390/nano10071403
    15. Blanco, E., Bey, E. A., Khemtong, C., Yang, S.-G., Setti-Guthi, J., Chen, H., Kessinger, C. W., Carnevale, K. A., Bornmann, W. G., Boothman, D. A., & Gao, J. (2010). Beta-lapachone micellar nanotherapeutics for non-small cell lung cancer therapy. Cancer Research, 70(10), 3896–3904. https://doi.org/10.1158/0008-5472.CAN-09-3995
    16. Blanco, E., Shen, H., & Ferrari, M. (2015). Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nature Biotechnology, 33(9), 941–951. https://doi.org/10.1038/nbt.3330
    17. Bozzuto, G., & Molinari, A. (2015). Liposomes as nanomedical devices. International Journal of Nanomedicine, 10, 975–999. https://doi.org/10.2147/IJN.S68861
    18. Brinks, J., Fowler, A., Franklin, B. A., & Dulai, J. (2017). Lifestyle Modification in Secondary Prevention: Beyond Pharmacotherapy. American Journal of Lifestyle Medicine, 11(2), 137–152. https://doi.org/10.1177/1559827616651402
    19. Burke, J. M., Morschhauser, F., Andorsky, D., Lee, C., & Sharman, J. P. (2020). Antibody-drug conjugates for previously treated aggressive lymphomas: focus on polatuzumab vedotin. Expert Review of Clinical Pharmacology, 13(10), 1073–1083. https://doi.org/10.1080/17512433.2020.1826303
    20. Caracciolo, G., Vali, H., Moore, A., & Mahmoudi, M. (2019). Challenges in molecular diagnostic research in cancer nanotechnology. Nano Today, 27, 6–10. https://doi.org/10.1016/j.nantod.2019.06.001
    21. Chalouni, C., & Doll, S. (2018). Fate of Antibody-Drug Conjugates in Cancer Cells. Journal of Experimental & Clinical Cancer Research, 37(1), 20. https://doi.org/10.1186/s13046-017-0667-1
    22. Chandrasekar, N., Steffi, A. P., Ramachandran, B., Hwang, M. T., Faramarzi, V., & Govarthanan, M. (2023). MXenes - Versatile 2D materials for identification of biomarkers and contaminants in large scale environments - A review. Environmental Research, 228, 115900. https://doi.org/10.1016/j.envres.2023.115900
    23. Charbe, N. B., Amnerkar, N. D., Ramesh, B., Tambuwala, M. M., Bakshi, H. A., Aljabali, A. A. A., Khadse, S. C., Satheeshkumar, R., Satija, S., Metha, M., Chellappan, D. K., Shrivastava, G., Gupta, G., Negi, P., Dua, K., & Zacconi, F. C. (2020). Small interfering RNA for cancer treatment: overcoming hurdles in delivery. Acta Pharmaceutica Sinica B, 10(11), 2075–2109. https://doi.org/https://doi.org/10.1016/j.apsb.2020.10.005
    24. Chaturvedi, V. K., Singh, A., Singh, V. K., & Singh, M. P. (2019). Cancer Nanotechnology: A New Revolution for Cancer Diagnosis and Therapy. Current Drug Metabolism, 20(6), 416–429. https://doi.org/10.2174/1389200219666180918111528
    25. Chen, H. H. W., & Kuo, M. T. (2017). Improving radiotherapy in cancer treatment: Promises and challenges. Oncotarget, 8(37), 62742–62758. https://doi.org/10.18632/oncotarget.18409
    26. Chen, X.-J., Zhang, X.-Q., Liu, Q., Zhang, J., & Zhou, G. (2018). Nanotechnology: a promising method for oral cancer detection and diagnosis. Journal of Nanobiotechnology, 16(1), 52. https://doi.org/10.1186/s12951-018-0378-6
    27. Chis, A. A., Dobrea, C., Morgovan, C., Arseniu, A. M., Rus, L. L., Butuca, A., Juncan, A. M., Totan, M., Vonica-Tincu, A. L., Cormos, G., Muntean, A. C., Muresan, M. L., Gligor, F. G., & Frum, A. (2020). Applications and Limitations of Dendrimers in Biomedicine. Molecules (Basel, Switzerland), 25(17). https://doi.org/10.3390/molecules25173982
    28. Cho, H., Jeon, S. I., Ahn, C.-H., Shim, M. K., & Kim, K. (2022). Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation. Pharmaceutics, 14(4). https://doi.org/10.3390/pharmaceutics14040728
    29. Das, S. K., Menezes, M. E., Bhatia, S., Wang, X.-Y., Emdad, L., Sarkar, D., & Fisher, P. B. (2015). Gene Therapies for Cancer: Strategies, Challenges and Successes. Journal of Cellular Physiology, 230(2), 259–271. https://doi.org/10.1002/jcp.24791
    30. Debele, T. A., Yeh, C.-F., & Su, W.-P. (2020). Cancer Immunotherapy and Application of Nanoparticles in Cancers Immunotherapy as the Delivery of Immunotherapeutic Agents and as the Immunomodulators. Cancers, 12(12). https://doi.org/10.3390/cancers12123773
    31. Deverka, P. A., Douglas, M. P., & Phillips, K. A. (2022). Multicancer Screening Tests: Anticipating And Addressing Considerations For Payer Coverage And Patient Access. Health Affairs (Project Hope), 41(3), 383–389. https://doi.org/10.1377/hlthaff.2021.01316
    32. Di Stasio, G. D., Buonomano, P., Travaini, L. L., Grana, C. M., & Mansi, L. (2021). From the Magic Bullet to Theragnostics: Certitudes and Hypotheses, Trying to Optimize the Somatostatin Model. Cancers, 13(14). https://doi.org/10.3390/cancers13143474
    33. Dichwalkar, T., Patel, S., Bapat, S., Pancholi, P., Jasani, N., Desai, B., Yellepeddi, V. K., & Sehdev, V. (2017). Omega-3 Fatty Acid Grafted PAMAM-Paclitaxel Conjugate Exhibits Enhanced Anticancer Activity in Upper Gastrointestinal Cancer Cells. Macromolecular Bioscience, 17(8). https://doi.org/10.1002/mabi.201600457
    34. Dik, G., Ulu, A., & Ateş, B. (2023). Synthesis and Biomedical Applications of Polymer-Functionalized Magnetic Nanoparticles. Nanofabrication, 8. https://doi.org/10.37819/nanofab.8.329
    35. Dillekås, H., Rogers, M. S., & Straume, O. (2019). Are 90% of deaths from cancer caused by metastases? Cancer Medicine, 8(12), 5574–5576. https://doi.org/10.1002/cam4.2474
    36. Doria, G., Conde, J., Veigas, B., Giestas, L., Almeida, C., Assunção, M., Rosa, J., & Baptista, P. V. (2012). Noble metal nanoparticles for biosensing applications. Sensors (Basel, Switzerland), 12(2), 1657–1687. https://doi.org/10.3390/s120201657
    37. Etrych, T., Braunova, A., Zogala, D., Lambert, L., Renesova, N., & Klener, P. (2022). Targeted Drug Delivery and Theranostic Strategies in Malignant Lymphomas. Cancers, 14(3). https://doi.org/10.3390/cancers14030626
    38. Fathi, M., Majidi, S., Zangabad, P. S., Barar, J., Erfan-Niya, H., & Omidi, Y. (2018). Chitosan-based multifunctional nanomedicines and theranostics for targeted therapy of cancer. Medicinal Research Reviews, 38(6), 2110–2136. https://doi.org/https://doi.org/10.1002/med.21506
    39. Franco, Y. L., Vaidya, T. R., & Ait-Oudhia, S. (2018). Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer. Breast Cancer (Dove Medical Press), 10, 131–141. https://doi.org/10.2147/BCTT.S170239
    40. Fu, S., Xia, J., & Wu, J. (2016). Functional Chitosan Nanoparticles in Cancer Treatment. Journal of Biomedical Nanotechnology, 12(8), 1585–1603. https://doi.org/10.1166/jbn.2016.2228
    41. Fu, Z., Li, S., Han, S., Shi, C., & Zhang, Y. (2022). Antibody drug conjugate: the “biological missile” for targeted cancer therapy. Signal Transduction and Targeted Therapy, 7(1), 93. https://doi.org/10.1038/s41392-022-00947-7
    42. Gabizon, A., Shmeeda, H., & Barenholz, Y. (2003). Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies. Clinical Pharmacokinetics, 42(5), 419–436. https://doi.org/10.2165/00003088-200342050-00002
    43. Gandini, A., & M Lacerda, T. (2021). Monomers and Macromolecular Materials from Renewable Resources: State of the Art and Perspectives. Molecules (Basel, Switzerland), 27(1). https://doi.org/10.3390/molecules27010159
    44. García-Pinel, B., Porras-Alcalá, C., Ortega-Rodríguez, A., Sarabia, F., Prados, J., Melguizo, C., & López-Romero, J. M. (2019). Lipid-Based Nanoparticles: Application and Recent Advances in Cancer Treatment. Nanomaterials (Basel, Switzerland), 9(4). https://doi.org/10.3390/nano9040638
    45. Gaucher, G., Dufresne, M.-H., Sant, V. P., Kang, N., Maysinger, D., & Leroux, J.-C. (2005). Block copolymer micelles: preparation, characterization and application in drug delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society, 109(1–3), 169–188. https://doi.org/10.1016/j.jconrel.2005.09.034
    46. Gavas, S., Quazi, S., & Karpiński, T. M. (2021). Nanoparticles for Cancer Therapy: Current Progress and Challenges. Nanoscale Research Letters, 16(1), 173. https://doi.org/10.1186/s11671-021-03628-6
    47. Grover, M., Behl, T., & Virmani, T. (2021). Phytochemical Screening, Antioxidant Assay and Cytotoxic Profile for Different Extracts of Chrysopogon zizanioides Roots. Chemistry & Biodiversity, 18(8), e2100012. https://doi.org/https://doi.org/10.1002/cbdv.202100012
    48. Gupta, D., Boora, A., Thakur, A., & Gupta, T. K. (2023). Green and sustainable synthesis of nanomaterials: Recent advancements and limitations. Environmental Research, 231, 116316. https://doi.org/https://doi.org/10.1016/j.envres.2023.116316
    49. Hafeez, U., Parakh, S., Gan, H. K., & Scott, A. M. (2020). Antibody–Drug Conjugates for Cancer Therapy. Molecules, 25(20). https://doi.org/10.3390/molecules25204764
    50. Haleem, A., Javaid, M., Singh, R. P., Rab, S., & Suman, R. (2023). Applications of nanotechnology in medical field: a brief review. Global Health Journal, 7(2), 70–77. https://doi.org/https://doi.org/10.1016/j.glohj.2023.02.008
    51. Harun, N. A., Benning, M. J., Horrocks, B. R., & Fulton, D. A. (2013). Gold nanoparticle-enhanced luminescence of silicon quantum dots co-encapsulated in polymer nanoparticles. Nanoscale, 5(9), 3817–3827. https://doi.org/10.1039/C3NR00421J
    52. He, Z., Wan, X., Schulz, A., Bludau, H., Dobrovolskaia, M. A., Stern, S. T., Montgomery, S. A., Yuan, H., Li, Z., Alakhova, D., Sokolsky, M., Darr, D. B., Perou, C. M., Jordan, R., Luxenhofer, R., & Kabanov, A. V. (2016). A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity. Biomaterials, 101, 296–309. https://doi.org/10.1016/j.biomaterials.2016.06.002
    53. Hong, S., Choi, D. W., Kim, H. N., Park, C. G., Lee, W., & Park, H. H. (2020). Protein-Based Nanoparticles as Drug Delivery Systems. Pharmaceutics, 12(7). https://doi.org/10.3390/pharmaceutics12070604
    54. Horejs, C. (2021). Nebulized lipid nanoparticles. Nature Reviews. Materials, 6(12), 1077. https://doi.org/10.1038/s41578-021-00392-y
    55. Hua, S., & Wu, S. Y. (2018). Editorial: Advances and Challenges in Nanomedicine. In Frontiers in pharmacology (Vol. 9, p. 1397). https://doi.org/10.3389/fphar.2018.01397
    56. Ibrahim, M., Abuwatfa, W. H., Awad, N. S., Sabouni, R., & Husseini, G. A. (2022). Encapsulation, Release, and Cytotoxicity of Doxorubicin Loaded in Liposomes, Micelles, and Metal-Organic Frameworks: A Review. Pharmaceutics, 14(2). https://doi.org/10.3390/pharmaceutics14020254
    57. Jain, D., Prajapati, S. K., Jain, A., & Singhal, R. (2023). Nano-formulated siRNA-based therapeutic approaches for cancer therapy. Nano Trends, 1, 100006. https://doi.org/https://doi.org/10.1016/j.nwnano.2023.100006
    58. Ji, T., Zhao, Y., Wang, J., Zheng, X., Tian, Y., Zhao, Y., & Nie, G. (2013). Tumor fibroblast specific activation of a hybrid ferritin nanocage-based optical probe for tumor microenvironment imaging. Small (Weinheim an Der Bergstrasse, Germany), 9(14), 2427–2431. https://doi.org/10.1002/smll.201300600
    59. Jia, S., Zhang, R., Li, Z., & Li, J. (2017). Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer. Oncotarget, 8(33), 55632–55645. https://doi.org/10.18632/oncotarget.17184
    60. Jiang, Y., Krishnan, N., Heo, J., Fang, R. H., & Zhang, L. (2020). Nanoparticle-hydrogel superstructures for biomedical applications. Journal of Controlled Release : Official Journal of the Controlled Release Society, 324, 505–521. https://doi.org/10.1016/j.jconrel.2020.05.041
    61. Jin, R., Guo, X., Dong, L., Xie, E., & Cao, A. (2017). Amphipathic dextran-doxorubicin prodrug micelles for solid tumor therapy. Colloids and Surfaces B: Biointerfaces, 158, 47–56. https://doi.org/https://doi.org/10.1016/j.colsurfb.2017.06.023
    62. Jou, J., Harrington, K. J., Zocca, M.-B., Ehrnrooth, E., & Cohen, E. E. W. (2021). The Changing Landscape of Therapeutic Cancer Vaccines-Novel Platforms and Neoantigen Identification. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 27(3), 689–703. https://doi.org/10.1158/1078-0432.CCR-20-0245
    63. Kager, L., Pötschger, U., & Bielack, S. (2010). Review of mifamurtide in the treatment of patients with osteosarcoma. Therapeutics and Clinical Risk Management, 6, 279–286. https://doi.org/10.2147/tcrm.s5688
    64. Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016). Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release. Chemical Reviews, 116(4), 2602–2663. https://doi.org/10.1021/acs.chemrev.5b00346
    65. Kang, B., Mackey, M. A., & El-Sayed, M. A. (2010). Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis. Journal of the American Chemical Society, 132(5), 1517–1519. https://doi.org/10.1021/ja9102698
    66. Kaur, H., Siwal, S. S., Kumar, V., & Thakur, V. K. (2023). Deep Eutectic Solvents toward the Detection and Extraction of Neurotransmitters: An Emerging Paradigm for Biomedical Applications. Industrial & Engineering Chemistry Research. https://doi.org/10.1021/acs.iecr.3c00410
    67. Kemp, J. A., & Kwon, Y. J. (2021). Cancer nanotechnology: current status and perspectives. Nano Convergence, 8(1), 34. https://doi.org/10.1186/s40580-021-00282-7
    68. Kemp, J. A., Shim, M. S., Heo, C. Y., & Kwon, Y. J. (2016). “Combo” nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy. Advanced Drug Delivery Reviews, 98, 3–18. https://doi.org/10.1016/j.addr.2015.10.019
    69. Koo, O. M., Rubinstein, I., & Onyuksel, H. (2005). Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine : Nanotechnology, Biology, and Medicine, 1(3), 193–212. https://doi.org/10.1016/j.nano.2005.06.004
    70. Kumar, B., Kumar, R., Skvortsova, I., & Kumar, V. (2017). Mechanisms of Tubulin Binding Ligands to Target Cancer Cells: Updates on their Therapeutic Potential and Clinical Trials. Current Cancer Drug Targets, 17(4), 357–375. https://doi.org/10.2174/1568009616666160928110818
    71. Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., & Muller, R. N. (2008). Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chemical Reviews, 108(6), 2064–2110. https://doi.org/10.1021/cr068445e
    72. Lee, C. C., Gillies, E. R., Fox, M. E., Guillaudeu, S. J., Fréchet, J. M. J., Dy, E. E., & Szoka, F. C. (2006). A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas. Proceedings of the National Academy of Sciences of the United States of America, 103(45), 16649–16654. https://doi.org/10.1073/pnas.0607705103
    73. Lee, E. S., Na, K., & Bae, Y. H. (2005). Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. Journal of Controlled Release : Official Journal of the Controlled Release Society, 103(2), 405–418. https://doi.org/10.1016/j.jconrel.2004.12.018
    74. Machtakova, M., Thérien-Aubin, H., & Landfester, K. (2022). Polymer nano-systems for the encapsulation and delivery of active biomacromolecular therapeutic agents. Chemical Society Reviews, 51(1), 128–152. https://doi.org/10.1039/d1cs00686j
    75. Maja, L., Željko, K., & Mateja, P. (2020). Sustainable technologies for liposome preparation. The Journal of Supercritical Fluids, 165, 104984. https://doi.org/https://doi.org/10.1016/j.supflu.2020.104984
    76. Malone, E. R., Oliva, M., Sabatini, P. J. B., Stockley, T. L., & Siu, L. L. (2020). Molecular profiling for precision cancer therapies. Genome Medicine, 12(1), 8. https://doi.org/10.1186/s13073-019-0703-1
    77. Mansoor, S., Kondiah, P. P. D., Choonara, Y. E., & Pillay, V. (2019). Polymer-Based Nanoparticle Strategies for Insulin Delivery. Polymers, 11(9), 1380. https://doi.org/10.3390/polym11091380
    78. Masuda, N., Ono, M., Mukohara, T., Yasojima, H., Shimoi, T., Kobayashi, K., Harano, K., Mizutani, M., Tanioka, M., Takahashi, S., Kogawa, T., Suzuki, T., Okumura, S., Takase, T., Nagai, R., Semba, T., Zhao, Z.-M., Ren, M., & Yonemori, K. (2022). Phase 1 study of the liposomal formulation of eribulin (E7389-LF): Results from the breast cancer expansion cohort. European Journal of Cancer (Oxford, England : 1990), 168, 108–118. https://doi.org/10.1016/j.ejca.2022.03.004
    79. McCombs, J. R., & Owen, S. C. (2015). Antibody drug conjugates: design and selection of linker, payload and conjugation chemistry. The AAPS Journal, 17(2), 339–351. https://doi.org/10.1208/s12248-014-9710-8
    80. McGarvey, N., Gitlin, M., Fadli, E., & Chung, K. C. (2022). Increased healthcare costs by later stage cancer diagnosis. BMC Health Services Research, 22(1), 1155. https://doi.org/10.1186/s12913-022-08457-6
    81. Milano, G., Innocenti, F., & Minami, H. (2022). Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs. Cancer Science, 113(7), 2224–2231. https://doi.org/10.1111/cas.15377
    82. Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021). Engineering precision nanoparticles for drug delivery. Nature Reviews Drug Discovery, 20(2), 101–124. https://doi.org/10.1038/s41573-020-0090-8
    83. Mocan, L., Matea, C., Tabaran, F. A., Mosteanu, O., Pop, T., Mocan, T., & Iancu, C. (2015). Photothermal treatment of liver cancer with albumin-conjugated gold nanoparticles initiates Golgi Apparatus-ER dysfunction and caspase-3 apoptotic pathway activation by selective targeting of Gp60 receptor. International Journal of Nanomedicine, 10, 5435–5445. https://doi.org/10.2147/IJN.S86495
    84. Moghimi-Dehkordi, B., & Safaee, A. (2012). An overview of colorectal cancer survival rates and prognosis in Asia. World Journal of Gastrointestinal Oncology, 4(4), 71–75. https://doi.org/10.4251/wjgo.v4.i4.71
    85. Namazi, H., Kulish, V. V, & Wong, A. (2015). Mathematical Modelling and Prediction of the Effect of Chemotherapy on Cancer Cells. Scientific Reports, 5(1), 13583. https://doi.org/10.1038/srep13583
    86. Navya, P. N., Kaphle, A., Srinivas, S. P., Bhargava, S. K., Rotello, V. M., & Daima, H. K. (2019). Current trends and challenges in cancer management and therapy using designer nanomaterials. Nano Convergence, 6(1), 23. https://doi.org/10.1186/s40580-019-0193-2
    87. Neelakandan, R. P., R, D., & N, D. (2023). Formulation and Evaluation of Mucoadhesive Buccal tablets using Nimodipine Solid Lipid Nanoparticles. Nanofabrication, 8. https://doi.org/10.37819/nanofab.008.296
    88. Nieto, C., Vega, M. A., & del Valle, E. M. (2020). Trastuzumab: More than a Guide in HER2-Positive Cancer Nanomedicine. Nanomaterials, 10(9). https://doi.org/10.3390/nano10091674
    89. Nirmala, M. J., Kizhuveetil, U., Johnson, A., G, B., Nagarajan, R., & Muthuvijayan, V. (2023). Cancer nanomedicine: a review of nano-therapeutics and challenges ahead. RSC Advances, 13(13), 8606–8629. https://doi.org/10.1039/d2ra07863e
    90. Ojha, A., Jaiswal, S., Bharti, P., & Mishra, S. K. (2022). Nanoparticles and Nanomaterials-Based Recent Approaches in Upgraded Targeting and Management of Cancer: A Review. Cancers, 15(1). https://doi.org/10.3390/cancers15010162
    91. Otmani, K., & Lewalle, P. (2021). Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications. Frontiers in Oncology, 11, 708765. https://doi.org/10.3389/fonc.2021.708765
    92. Park, E. J. (2022). Tailoring strategies for colorectal cancer screening and treatment based on age in colorectal cancer patients. In Annals of coloproctology (Vol. 38, Issue 3, pp. 181–182). https://doi.org/10.3393/ac.2022.00395.0056
    93. Parodi, A., Kolesova, E. P., Voronina, M. V, Frolova, A. S., Kostyushev, D., Trushina, D. B., Akasov, R., Pallaeva, T., & Zamyatnin, A. A. J. (2022). Anticancer Nanotherapeutics in Clinical Trials: The Work behind Clinical Translation of Nanomedicine. International Journal of Molecular Sciences, 23(21). https://doi.org/10.3390/ijms232113368
    94. Parodi, A., Miao, J., Soond, S. M., Rudzińska, M., & Zamyatnin, A. A. (2019). Albumin Nanovectors in Cancer Therapy and Imaging. In Biomolecules (Vol. 9, Issue 6). https://doi.org/10.3390/biom9060218
    95. Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007). Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology, 2(12), 751–760. https://doi.org/10.1038/nnano.2007.387
    96. Petkar, K. C., Patil, S. M., Chavhan, S. S., Kaneko, K., Sawant, K. K., Kunda, N. K., & Saleem, I. Y. (2021). An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery. Pharmaceutics, 13(4). https://doi.org/10.3390/pharmaceutics13040455
    97. Petre, C. E., & Dittmer, D. P. (2007). Liposomal daunorubicin as treatment for Kaposi’s sarcoma. International Journal of Nanomedicine, 2(3), 277–288.
    98. Piffoux, M., Silva, A. K. A., Wilhelm, C., Gazeau, F., & Tareste, D. (2018). Modification of Extracellular Vesicles by Fusion with Liposomes for the Design of Personalized Biogenic Drug Delivery Systems. ACS Nano, 12(7), 6830–6842. https://doi.org/10.1021/acsnano.8b02053
    99. Pillaiyar, T., Meenakshisundaram, S., Manickam, M., & Sankaranarayanan, M. (2020). A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery. European Journal of Medicinal Chemistry, 195, 112275. https://doi.org/10.1016/j.ejmech.2020.112275
    100. Prakash, N., Balaji, R., Chen, S.-M., Steffi, A. P., Tamilalagan, E., Narendhar, C., & Muthusankar, E. (2021). Investigation of template-assisted (MCM-41) mesoporous Co3O4 nanostructures and its superior supercapacitive retention. Vacuum, 185, 109998. https://doi.org/https://doi.org/10.1016/j.vacuum.2020.109998
    101. Prakash, N., Balaji, R., Govindaraju, S., Steffi, A. P., Santhanalakshmi, N., Mohanraj, K., Selvarajan, E., Chandrasekar, N., & Samuel, M. S. (2022). Influence of 2D template-assisted (SBA-15) metal oxide Co3O4 for pseudocapacitive and dye degradation application. Environmental Research, 204, 112383. https://doi.org/https://doi.org/10.1016/j.envres.2021.112383
    102. Rai, R., Alwani, S., & Badea, I. (2019). Polymeric Nanoparticles in Gene Therapy: New Avenues of Design and Optimization for Delivery Applications. Polymers, 11(4). https://doi.org/10.3390/polym11040745
    103. Ramesh, M., Janani, R., Deepa, C., & Rajeshkumar, L. (2023). Nanotechnology-Enabled Biosensors: A Review of Fundamentals, Design Principles, Materials, and Applications. Biosensors, 13(1). https://doi.org/10.3390/bios13010040
    104. Rasool, M., Malik, A., Waquar, S., Arooj, M., Zahid, S., Asif, M., Shaheen, S., Hussain, A., Ullah, H., & Gan, S. H. (2022). New challenges in the use of nanomedicine in cancer therapy. Bioengineered, 13(1), 759–773. https://doi.org/10.1080/21655979.2021.2012907
    105. Reang, J., Sharma, K., Sharma, P. C., Yadav, V., Sharma, V., & Majeed, J. (2023). Discovery of VEGFR inhibitors through virtual screening and energy assessment. Journal of Biochemical and Molecular Toxicology, n/a(n/a), e23321. https://doi.org/https://doi.org/10.1002/jbt.23321
    106. Reang, J., Sharma, P. C., Thakur, V. K., & Majeed, J. (2021). Understanding the Therapeutic Potential of Ascorbic Acid in the Battle to Overcome Cancer. In Biomolecules (Vol. 11, Issue 8). https://doi.org/10.3390/biom11081130
    107. Rimkus, T., Sirkisoon, S., Harrison, A., & Lo, H.-W. (2017). Tumor suppressor candidate 2 (TUSC2, FUS-1) and human cancers. Discovery Medicine, 23(128), 325–330.
    108. Roma-Rodrigues, C., Rivas-García, L., Baptista, P. V, & Fernandes, A. R. (2020). Gene Therapy in Cancer Treatment: Why Go Nano? In Pharmaceutics (Vol. 12, Issue 3). https://doi.org/10.3390/pharmaceutics12030233
    109. Rosa, W. E., & Hassmiller, S. B. (2020). The Sustainable Development Goals and Building a Culture of Health. The American Journal of Nursing, 120(6), 69–71. https://doi.org/10.1097/01.NAJ.0000668772.33792.1f
    110. Ryu, J. H., Koo, H., Sun, I.-C., Yuk, S. H., Choi, K., Kim, K., & Kwon, I. C. (2012). Tumor-targeting multi-functional nanoparticles for theragnosis: New paradigm for cancer therapy. Advanced Drug Delivery Reviews, 64(13), 1447–1458. https://doi.org/https://doi.org/10.1016/j.addr.2012.06.012
    111. Ryu, J. H., Lee, S., Son, S., Kim, S. H., Leary, J. F., Choi, K., & Kwon, I. C. (2014). Theranostic nanoparticles for future personalized medicine. Journal of Controlled Release : Official Journal of the Controlled Release Society, 190, 477–484. https://doi.org/10.1016/j.jconrel.2014.04.027
    112. Salehi, B., Selamoglu, Z., S Mileski, K., Pezzani, R., Redaelli, M., Cho, W. C., Kobarfard, F., Rajabi, S., Martorell, M., Kumar, P., Martins, N., Subhra Santra, T., & Sharifi-Rad, J. (2019). Liposomal Cytarabine as Cancer Therapy: From Chemistry to Medicine. Biomolecules, 9(12). https://doi.org/10.3390/biom9120773
    113. Sauraj, Kumar, A., Kumar, B., Kulshreshtha, A., & Negi, Y. S. (2021). Redox-sensitive nanoparticles based on xylan-lipoic acid conjugate for tumor targeted drug delivery of niclosamide in cancer therapy. Carbohydrate Research, 499, 108222. https://doi.org/https://doi.org/10.1016/j.carres.2020.108222
    114. Sauraj, Vinay kumar, Kumar, B., Priyadarshi, R., Deeba, F., Kulshreshtha, A., Kumar, A., Agrawal, G., Gopinath, P., & Negi, Y. S. (2020). Redox responsive xylan-SS-curcumin prodrug nanoparticles for dual drug delivery in cancer therapy. Materials Science and Engineering: C, 107, 110356. https://doi.org/https://doi.org/10.1016/j.msec.2019.110356
    115. Shams, F., Golchin, A., Azari, A., Mohammadi Amirabad, L., Zarein, F., Khosravi, A., & Ardeshirylajimi, A. (2022). Nanotechnology-based products for cancer immunotherapy. Molecular Biology Reports, 49(2), 1389–1412. https://doi.org/10.1007/s11033-021-06876-y
    116. Sheoran, S., Arora, S., Samsonraj, R., Govindaiah, P., & Vuree, S. (2022). Lipid-based nanoparticles for treatment of cancer. Heliyon, 8(5), e09403. https://doi.org/10.1016/j.heliyon.2022.e09403
    117. Shrestha, B., Wang, L., Brey, E. M., Uribe, G. R., & Tang, L. (2021). Smart Nanoparticles for Chemo-Based Combinational Therapy. Pharmaceutics, 13(6). https://doi.org/10.3390/pharmaceutics13060853
    118. Siafaka, P. I., Okur, N. Ü., Karantas, I. D., Okur, M. E., & Gündoğdu, E. A. (2021). Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities. Asian Journal of Pharmaceutical Sciences, 16(1), 24–46. https://doi.org/https://doi.org/10.1016/j.ajps.2020.03.003
    119. Silverman, J., & Deitcher, S. (2012). Marqibo(R) (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine. Cancer Chemotherapy and Pharmacology, 71. https://doi.org/10.1007/s00280-012-2042-4
    120. Sochacka-Ćwikła, A., Mączyński, M., & Regiec, A. (2022). FDA-Approved Small Molecule Compounds as Drugs for Solid Cancers from Early 2011 to the End of 2021. Molecules (Basel, Switzerland), 27(7). https://doi.org/10.3390/molecules27072259
    121. Song, S., Qin, Y., He, Y., Huang, Q., Fan, C., & Chen, H.-Y. (2010). Functional nanoprobes for ultrasensitive detection of biomolecules. Chemical Society Reviews, 39(11), 4234–4243. https://doi.org/10.1039/C000682N
    122. Steffi, A. P., Balaji, R., Chandrasekar, N., Prakash, N., Rajesh, T. P., Ethiraj, S., Samuel, M. S., & Vuppala, S. (2022). High-performance anti-corrosive coatings based on rGO-SiO2-TiO2 ternary heterojunction nanocomposites for superior protection for mild steel specimens. Diamond and Related Materials, 125, 108968. https://doi.org/https://doi.org/10.1016/j.diamond.2022.108968
    123. Steffi, A. P., Balaji, R., Prakash, N., Rajesh, T. P., Ethiraj, S., Samuel, M. S., Nadda, A. K., & Chandrasekar, N. (2022). Incorporation of SiO(2) functionalized gC(3)N(4) sheets with TiO(2) nanoparticles to enhance the anticorrosion performance of metal specimens in aggressive Cl(-) environment. Chemosphere, 290, 133332. https://doi.org/10.1016/j.chemosphere.2021.133332
    124. Su, D., & Zhang, D. (2021). Linker Design Impacts Antibody-Drug Conjugate Pharmacokinetics and Efficacy via Modulating the Stability and Payload Release Efficiency. Frontiers in Pharmacology, 12, 687926. https://doi.org/10.3389/fphar.2021.687926
    125. Su, W.-P., Cheng, F.-Y., Shieh, D.-B., Yeh, C.-S., & Su, W.-C. (2012). PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells. International Journal of Nanomedicine, 7, 4269–4283. https://doi.org/10.2147/IJN.S33666
    126. Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016). PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Advanced Drug Delivery Reviews, 99(Pt A), 28–51. https://doi.org/10.1016/j.addr.2015.09.012
    127. Sun, X., Bao, J., & Shao, Y. (2016). Mathematical Modeling of Therapy-induced Cancer Drug Resistance: Connecting Cancer Mechanisms to Population Survival Rates. Scientific Reports, 6(1), 22498. https://doi.org/10.1038/srep22498
    128. Syed, Y. Y. (2020). Sacituzumab Govitecan: First Approval. Drugs, 80(10), 1019–1025. https://doi.org/10.1007/s40265-020-01337-5
    129. Tawfik, S. M., Azizov, S., Elmasry, M. R., Sharipov, M., & Lee, Y.-I. (2021). Recent Advances in Nanomicelles Delivery Systems. In Nanomaterials (Vol. 11, Issue 1). https://doi.org/10.3390/nano11010070
    130. Tian, Z., Liang, G., Cui, K., Liang, Y., Wang, Q., Lv, S., Cheng, X., & Zhang, L. (2021). Insight Into the Prospects for RNAi Therapy of Cancer . In Frontiers in Pharmacology (Vol. 12). https://www.frontiersin.org/articles/10.3389/fphar.2021.644718
    131. van der Meel, R., Sulheim, E., Shi, Y., Kiessling, F., Mulder, W. J. M., & Lammers, T. (2019). Smart cancer nanomedicine. Nature Nanotechnology, 14(11), 1007–1017. https://doi.org/10.1038/s41565-019-0567-y
    132. Vasan, N., Baselga, J., & Hyman, D. M. (2019). A view on drug resistance in cancer. Nature, 575(7782), 299–309. https://doi.org/10.1038/s41586-019-1730-1
    133. Vijayan, V., Reddy, K. R., Sakthivel, S., & Swetha, C. (2013). Optimization and charaterization of repaglinide biodegradable polymeric nanoparticle loaded transdermal patchs: in vitro and in vivo studies. Colloids and Surfaces. B, Biointerfaces, 111, 150–155. https://doi.org/10.1016/j.colsurfb.2013.05.020
    134. Vlek, C., Skolnik, M., & Gatersleben, B. (1998). Sustainable development and quality of life: expected effects of prospective changes in economic and environmental conditions. Zeitschrift Fur Experimentelle Psychologie : Organ Der Deutschen Gesellschaft Fur Psychologie, 45(4), 319–333.
    135. Wang, K., Kievit, F. M., & Zhang, M. (2016). Nanoparticles for cancer gene therapy: Recent advances, challenges, and strategies. Pharmacological Research, 114, 56–66. https://doi.org/https://doi.org/10.1016/j.phrs.2016.10.016
    136. Wang, K., Shen, R., Meng, T., Hu, F., & Yuan, H. (2022). Nano-Drug Delivery Systems Based on Different Targeting Mechanisms in the Targeted Therapy of Colorectal Cancer. Molecules (Basel, Switzerland), 27(9). https://doi.org/10.3390/molecules27092981
    137. Xu, S., Wang, L., & Liu, Z. (2021). Molecularly Imprinted Polymer Nanoparticles: An Emerging Versatile Platform for Cancer Therapy. Angewandte Chemie International Edition, 60(8), 3858–3869. https://doi.org/https://doi.org/10.1002/anie.202005309
    138. Xue, Y., Gao, Y., Meng, F., & Luo, L. (2021). Recent progress of nanotechnology-based theranostic systems in cancer treatments. Cancer Biology & Medicine, 18(2), 336–351. https://doi.org/10.20892/j.issn.2095-3941.2020.0510
    139. Yadav, V., Reang, J., Sharma, V., Majeed, J., Sharma, P. C., Sharma, K., Giri, N., Kumar, A., & Tonk, R. K. (2022). Quinoline-derivatives as privileged scaffolds for medicinal and pharmaceutical chemists: A comprehensive review. Chemical Biology & Drug Design, 100(3), 389–418. https://doi.org/https://doi.org/10.1111/cbdd.14099
    140. Yadav, V., Tonk, K. R., & Khatri, R. (2021). Molecular Docking, 3D-QSAR, Fingerprint-Based 2D-QSAR, Analysis of Pyrimidine, and Analogs of ALK (Anaplastic Lymphoma Kinase) Inhibitors as an Anticancer Agent. In Letters in Drug Design & Discovery (Vol. 18, Issue 5, pp. 509–521). https://doi.org/http://dx.doi.org/10.2174/1570180817999201123163617
    141. Yang, J., Arya, S., Lung, P., Lin, Q., Huang, J., & Li, Q. (2019). Hybrid nanovaccine for the co-delivery of the mRNA antigen and adjuvant. Nanoscale, 11(45), 21782–21789. https://doi.org/10.1039/C9NR05475H
    142. Yao, Y., Zhou, Y., Liu, L., Xu, Y., Chen, Q., Wang, Y., Wu, S., Deng, Y., Zhang, J., & Shao, A. (2020). Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance . In Frontiers in Molecular Biosciences (Vol. 7). https://www.frontiersin.org/articles/10.3389/fmolb.2020.00193
    143. Yuan, H., Guo, H., Luan, X., He, M., Li, F., Burnett, J., Truchan, N., & Sun, D. (2020). Albumin Nanoparticle of Paclitaxel (Abraxane) Decreases while Taxol Increases Breast Cancer Stem Cells in Treatment of Triple Negative Breast Cancer. Molecular Pharmaceutics, 17(7), 2275–2286. https://doi.org/10.1021/acs.molpharmaceut.9b01221
    144. Yue, X., & Dai, Z. (2018). Liposomal Nanotechnology for Cancer Theranostics. Current Medicinal Chemistry, 25(12), 1397–1408. https://doi.org/10.2174/0929867324666170306105350
    145. Zeng, Y., Li, S., Zhang, S., Wang, L., Yuan, H., & Hu, F. (2022). Cell membrane coated-nanoparticles for cancer immunotherapy. Acta Pharmaceutica Sinica. B, 12(8), 3233–3254. https://doi.org/10.1016/j.apsb.2022.02.023
    146. Zhang, E., Xing, R., Liu, S., & Li, P. (2019). Current advances in development of new docetaxel formulations. Expert Opinion on Drug Delivery, 16(3), 301–312. https://doi.org/10.1080/17425247.2019.1583644
    147. Zhang, H., Lv, J., & Jia, Z. (2017). Efficient Fluorescence Resonance Energy Transfer between Quantum Dots and Gold Nanoparticles Based on Porous Silicon Photonic Crystal for DNA Detection. In Sensors (Vol. 17, Issue 5). https://doi.org/10.3390/s17051078
    148. Zhang, S., Jiang, S.-F., Huang, B.-C., Shen, X.-C., Chen, W.-J., Zhou, T.-P., Cheng, H.-Y., Cheng, B.-H., Wu, C.-Z., Li, W.-W., Jiang, H., & Yu, H.-Q. (2020). Sustainable production of value-added carbon nanomaterials from biomass pyrolysis. Nature Sustainability, 3(9), 753–760. https://doi.org/10.1038/s41893-020-0538-1
    149. Zhang, Y., Li, M., Gao, X., Chen, Y., & Liu, T. (2019). Nanotechnology in cancer diagnosis: progress, challenges and opportunities. Journal of Hematology & Oncology, 12(1), 137. https://doi.org/10.1186/s13045-019-0833-3
    150. Zhang, Y., Poon, K., Masonsong, G. S. P., Ramaswamy, Y., & Singh, G. (2023). Sustainable Nanomaterials for Biomedical Applications. In Pharmaceutics (Vol. 15, Issue 3). https://doi.org/10.3390/pharmaceutics15030922
    151. Zhao, P., Tang, X., & Huang, Y. (2021). Teaching new tricks to old dogs: A review of drug repositioning of disulfiram for cancer nanomedicine. VIEW, 2(4), 20200127. https://doi.org/https://doi.org/10.1002/VIW.20200127
    152. Zheng, S., Wang, J., Ding, N., Chen, W., Chen, H., Xue, M., Chen, F., Ni, J., Wang, Z., Lin, Z., Jiang, H., Liu, X., & Wang, L. (2021). Prodrug polymeric micelles integrating cancer-associated fibroblasts deactivation and synergistic chemotherapy for gastric cancer. Journal of Nanobiotechnology, 19(1), 381. https://doi.org/10.1186/s12951-021-01127-5
    153. Zhou, L., Zou, M., Xu, Y., Lin, P., Lei, C., & Xia, X. (2022). Nano Drug Delivery System for Tumor Immunotherapy: Next-Generation Therapeutics. Frontiers in Oncology, 12, 864301. https://doi.org/10.3389/fonc.2022.864301

    How to Cite

    Advancements and application of sustainable nanotechnology-based biomedical products in cancer therapeutics. (2023). Nanofabrication, 8. https://doi.org/10.37819/nanofab.8.1772
    ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
    Download Citation
    Endnote/Zotero/Mendeley (RIS) BibTeX

    How to Cite

    Advancements and application of sustainable nanotechnology-based biomedical products in cancer therapeutics. (2023). Nanofabrication, 8. https://doi.org/10.37819/nanofab.8.1772

    HTML
    171

    Total
    260

    Share

    Search Panel

    Vinita Sharma
    Google Scholar
    Pubmed
    JDMFS Journal

    Jurnal Reang
    Google Scholar
    Pubmed
    JDMFS Journal

    Vivek Yadav
    Google Scholar
    Pubmed
    JDMFS Journal

    Archana Sharma
    Google Scholar
    Pubmed
    JDMFS Journal

    Jaseela Majeed
    Google Scholar
    Pubmed
    JDMFS Journal

    Prabodh Chander Sharma
    Google Scholar
    Pubmed
    JDMFS Journal

    Downloads

    Article Details

    Most Read This Month

    License

    Copyright (c) 2023 Vinita Sharma, Jurnal Reang, Vivek Yadav, Archana Sharma, Jaseela Majeed, Prabodh Chander Sharma

    Creative Commons License

    This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

    Copyright © 2023 EurAsia Academic Publishing Group. All rights reserved